Roche Holding AG
RHHBY | OTC
$55.45
+$0.15 (+0.27%)
Sep 22, 2026, 12:46 PM ET · Market open
TTM Period Ending | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 46.57B | 61.4B | 61.42B | 60.44B | 60.77B | 63.28B | 64.38B | 62.8B | 59.76B | 58.32B | 60.28B |
Cost of Revenue | 12.32B | 15.92B | 15.75B | 15.82B | 16.63B | 18.84B | 20.22B | 19.71B | 17.69B | 16.36B | 16.99B |
Gross Profit | 34.25B | 45.48B | 43.94B | 42.9B | 44.14B | 44.44B | 44.17B | 43.1B | 42.06B | 41.96B | 43.28B |
Operating Income | 13.21B | 17.11B | 15.01B | 15.4B | 17.36B | 18.18B | 18.33B | 17.28B | 17.11B | 17.72B | 18.38B |
Interest Income | n/a | n/a | 294M | 633M | 653M | 568M | 428M | 177M | 5M | 16M | 239M |
Pretax Income | 8.38B | 11.81B | 13.11B | 14.08B | 14.55B | 16.37B | 18.52B | 17.4B | 17.67B | 17.97B | 16.45B |
Net Income | 5.72B | 8.28B | 10.62B | 11.5B | 11.03B | 12.42B | 14.66B | 13.93B | 14.02B | 14.3B | 12.96B |
Selling & General & Admin | 10.55B | 13.71B | 13.17B | 13.11B | 12.86B | 12.03B | 11.98B | 11.87B | 11.65B | 11.82B | 12.72B |
Research & Development | 10.11B | 14.16B | 14.33B | 13.23B | 13.72B | 14.05B | 13.65B | 13.71B | 13.06B | 12.15B | 11.92B |
Other Expenses | 4.71B | 4.83B | 484M | 115M | n/a | n/a | -136M | -136M | -144M | -265M | -266M |
Operating Expenses | 25.37B | 32.7B | 27.98B | 26.55B | 26.78B | 26.27B | 25.84B | 25.82B | 24.95B | 24.24B | 24.9B |
Interest Expense | 623M | 1.25B | 1.05B | 828M | 755M | 608M | 428M | 341M | 380M | 438M | 517M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 5.17B | 9.48B | 9.17B | 9.39B | 10.26B |
Cost & Expenses | 38.05B | 48.98B | 46.41B | 45.05B | 43.4B | 45.11B | 46.06B | 45.52B | 42.65B | 40.6B | 41.9B |
Income Tax Expense | 1.96B | 2.61B | 1.58B | 1.67B | 2.58B | 2.8B | 2.62B | 2.46B | 2.85B | 2.9B | 2.77B |
Shares Outstanding (Basic) | 6.42B | 6.36B | 6.38B | 6.38B | 6.39B | 6.39B | 6.47B | 6.76B | 6.83B | 6.84B | 6.84B |
Shares Outstanding (Diluted) | 6.42B | 6.42B | 6.42B | 6.43B | 6.43B | 6.39B | 6.48B | 6.86B | 6.9B | 6.91B | 6.93B |
EPS (Basic) | 0.90 | 1.30 | 1.67 | 1.80 | 1.73 | 1.93 | 2.22 | 2.05 | 2.05 | 2.09 | 1.89 |
EPS (Diluted) | 0.89 | 1.29 | 1.65 | 1.79 | 1.72 | 1.93 | 2.21 | 2.03 | 2.03 | 2.07 | 1.87 |
EBITDA | 12.5B | 16.51B | 17.6B | 18.41B | 21.48B | 23.31B | 23.02B | 22.19B | 22.7B | 22.98B | 24.09B |
EBIT | 9.96B | 13.09B | 14.22B | 14.94B | 17.96B | 19.62B | 18.94B | 17.74B | 18.05B | 18.4B | 19.85B |
Depreciation & Amortization | 2.54B | 3.42B | 3.38B | 3.47B | 3.67B | 3.82B | 4.08B | 4.45B | 4.64B | 4.57B | 4.44B |
Add to Watchlist
Select watchlists to add or remove RHHBY